Literature DB >> 21210288

Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis.

Wei Wang1, Jinming Li.   

Abstract

Analysis of IgG subclass distribution of antibodies may provide insights into the mechanisms driving antibody production. Here, we have first determined IgG subclass distribution of anti-recombinant peptidylarginine deiminase 4 (anti-hPADI4) antibodies in sera from patients with rheumatoid arthritis (RA). Sera from 103 RA patients were screened to IgG anti-PADI4 using recombinant antigens. For positive samples, the subclass distribution of IgG anti-hPADI4 was determined by means of establishing the equipotency of four HRP-labeled IgG subclass-specific monoclonal antibodies. The subclass profiles were compared among individuals with different disease status. Thirty-three out of 103 RA patients were determined as IgG anti-hPADI4-positive. As expressed by percentage levels to total IgG anti-hPADI4 activity, IgG1 and IgG3 were determined to be the predominant subclasses of anti-hPADI4. Furthermore, distinct subclass distribution patterns were observed in patients with different disease status. The IgG subclass distribution of anti-hPADI4 indicates that a leading T lymphocyte-regulated IgG1 and IgG3 responses may contribute to a better understanding of the role of anti-PADI4 in RA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21210288     DOI: 10.1007/s10067-010-1671-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

1.  Epitopes, immunoglobulin classes and immunoglobulin G subclasses of calsequestrin antibodies in patients with thyroid eye disease.

Authors:  Sofie de Haan; Hooshang Lahooti; Olivia Morris; Jack R Wall
Journal:  Autoimmunity       Date:  2010-07-29       Impact factor: 2.815

Review 2.  Human IgG subclass measurements in the clinical laboratory.

Authors:  R G Hamilton
Journal:  Clin Chem       Date:  1987-10       Impact factor: 8.327

3.  IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin.

Authors:  S Chapuy-Regaud; L Nogueira; C Clavel; M Sebbag; C Vincent; G Serre
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

4.  IgG subclass distribution of antibodies against beta(2)-GP1 and cardiolipin in patients with systemic lupus erythematosus and primary antiphospholipid syndrome, and their clinical associations.

Authors:  M Samarkos; K A Davies; C Gordon; M J Walport; S Loizou
Journal:  Rheumatology (Oxford)       Date:  2001-09       Impact factor: 7.580

5.  The subclass distribution of human IgG rheumatoid factor.

Authors:  P L Cohen; R L Cheek; J A Hadler; W J Yount; R A Eisenberg
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

Review 6.  Citrullination by peptidylarginine deiminase in rheumatoid arthritis.

Authors:  Akari Suzuki; Ryo Yamada; Kazuhiko Yamamoto
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

7.  IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA.

Authors:  R Engelmann; J Brandt; M Eggert; K Karberg; A Krause; G Neeck; B Mueller-Hilke
Journal:  Rheumatology (Oxford)       Date:  2008-08-13       Impact factor: 7.580

8.  Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria.

Authors:  J Fransen; M C W Creemers; P L C M Van Riel
Journal:  Rheumatology (Oxford)       Date:  2004-07-06       Impact factor: 7.580

9.  Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation.

Authors:  Céline Foulquier; Mireille Sebbag; Cyril Clavel; Sabine Chapuy-Regaud; Roula Al Badine; Marie-Claire Méchin; Christian Vincent; Rachida Nachat; Michiyuki Yamada; Hidenari Takahara; Michel Simon; Marina Guerrin; Guy Serre
Journal:  Arthritis Rheum       Date:  2007-11

10.  Clinical significance of IgG subclasses of Anti-Sm and U1 ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease.

Authors:  Y Tokano; M Yasuma; S Harada; Y Takasaki; H Hashimoto; K Okumura; S Hirose
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

View more
  7 in total

1.  Evaluation of serum immunoglobulins concentrations and distributions in vitiligo patients.

Authors:  Yulong Li; Min Yang; Rui Zhang; Wan Liu; Kuo Zhang; Wei Wen; Lang Yi; Qiaoxian Wang; Mingju Hao; Hui Yang; Jianmin Chang; Jinming Li
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

2.  Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations.

Authors:  Elizabeth D Ferucci; Erika Darrah; Irene Smolik; Tammy L Choromanski; David B Robinson; Marianna M Newkirk; Marvin J Fritzler; Antony Rosen; Hani S El-Gabalawy
Journal:  J Rheumatol       Date:  2013-08-01       Impact factor: 4.666

3.  Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.

Authors:  Yanli Zeng; Yiqiang Lin; Xuelian Wang; Yan Zhang; Feng Peng; JiaJia Wang; Longcan Jiang; Shiqiong Liang; Yun Xiao
Journal:  Clin Rheumatol       Date:  2020-03-18       Impact factor: 2.980

4.  Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis.

Authors:  Jiaqi Ren; Lin Sun; Jinxia Zhao
Journal:  Clin Rheumatol       Date:  2017-09-08       Impact factor: 2.980

5.  Autoantibodies against the catalytic domain of BRAF are not specific serum markers for rheumatoid arthritis.

Authors:  Wenli Li; Wei Wang; Shipeng Sun; Yu Sun; Yang Pan; Lunan Wang; Rui Zhang; Kuo Zhang; Jinming Li
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

6.  IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis.

Authors:  Thomas Gelsing Carlsen; Astrid Hjelholt; Anne Grethe Jurik; Berit Schiøttz-Christensen; Anna Zejden; Gunna Christiansen; Bent Deleuran; Svend Birkelund
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

7.  Neurological disorders-associated anti-glycosphingolipid IgG-antibodies display differentially restricted IgG subclass distribution.

Authors:  Ricardo D Lardone; Fernando J Irazoqui; Gustavo A Nores
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.